![Logo MCSA [logo]](/templates/chamber/images/logo.svg){kind=logo}
Tracking progress through evolving health strategies: 2025–2030
Explore our evolving strategy documents that guide the Masoyise Health Programme performance. The 2023–2024 strategy introduced mental health as a core focus, while the 2025–2030 strategy expands support for women’s health and wellbeing. Achievements include a drop in TB incidence to 223 per 100,000 and over 80% screening rates for HIV and NCDs. Download the strategy documents below.
DOWNLOAD 2025–2030 STRATEGY > DOWNLOAD 2023–2024 STRATEGY >
Industry performance against targets: 2020 to 2024
| Activity | Milestone | 2020 | 2021 | 2022 | 2023 | 2024 |
| Compliance to reporting | Companies on the system | 280 | 281 | 280 | 286 | 289 |
| 100% | 91.5% | 91.2% | 90.4% | 93.8% | ||
| HIV counselling, testing and ART treatment | HIV counselling | 67.3% | 67.1% | 81.7% | 91.4% | 81.6% |
| Annual HIV test (100%) | 43% | 49% | 63.7% | 62.7% | 75.2% | |
| ART Treatment | 56.2% | 46.4% | 47.1% | 44.3% | 43.1% | |
| TB screening | Annual TB screening (100%) | 68% | 75.4% | 81.7% | 92.7% | 85.6% |
| TB incidence | Below the national TB incidence rate 5% year on year reduction for the TB incidence rate |
195 per 100 000 population |
221 per 100 000 population |
244 per 100 000 population |
229 per 100 000 population |
162 per 100 000 population |
| NCDs | Employees screened for hypertension (100%) | 100% | 74% | 81.7% | 92.1% | 87.9% |
| Employees screened for diabetes (100%) | 100% | 59% | 80% | 91.5% | 84.1% | |
| Employees screened for obesity (100%) | 100% | 0% | 0% | 87.3% | 83.2% | |
| Employees screened for cholesterol (100%) | 100% | 0% | 0% | 32.6% | 27.5% | |
| Employees screened for mental health issues (100%) | 100% | 0% | 0% | 11.4% | 67.7% |